Halozyme Therapeutics (HALO) Net Margin Growth (5y) (2015 - 2026)
Halozyme Therapeutics (HALO) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Halozyme Therapeutics |
8.24 Bn |
7.92 Bn |
297.47 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
850.00 |
| Dec 31, 2025 |
-9,146.00 |
| Sep 30, 2025 |
-596.00 |
| Jun 30, 2025 |
395.00 |
| Mar 31, 2025 |
6,866.00 |
| Dec 31, 2024 |
11,007.00 |
| Sep 30, 2024 |
10,134.00 |
| Jun 30, 2024 |
7,766.00 |
| Mar 31, 2024 |
3,607.00 |
| Dec 31, 2023 |
4,065.00 |
| Sep 30, 2023 |
14,686.00 |
| Jun 30, 2023 |
9,885.00 |
| Mar 31, 2023 |
11,338.00 |
| Dec 31, 2022 |
-3,356.00 |
| Sep 30, 2022 |
2,518.00 |
| Jun 30, 2022 |
10,604.00 |
| Mar 31, 2022 |
16,251.00 |
| Dec 31, 2021 |
13,567.00 |
| Sep 30, 2021 |
27,786.00 |
| Jun 30, 2021 |
14,764.00 |
